Skip to main content

Table 1 Baseline patient characteristics and laboratory values

From: Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective long-term follow-up study

Variable N (%)/Median (IQR)/Mean (SD)
Male (%)
Female (%)
74 (54)
63 (46)
Age (years) 66 (52–71)
Haemodialysis (%) 85 (61.6)
CKD stage 4–5 (%) 52 (38.4)
Haemodialysis vintage (months) 25 (10.0–53)
Hypertension (%) 123 (89)
Diabetes mellitus (%) 38 (27.7)
Smoker (%) 30 (18.4)
Chronic ischemic heart disease (%) 27 (20.1)
Previous stroke event (%) 15 (11.3)
Previous cardiologic event (%) 35 (26.3)
Antiplatelet therapy (%) 48 (35.0)
Statin therapy (%) 59 (43.1)
Vitamin D therapy (%) 72 (53.3)
Calcium salt use (%) 73 (54.1)
Phosphate binder use (%) 57 (42.5)
Cinacalcet treatment (%) 9 (6.70)
CACI score (HU) 137
 1 (0) 18 (13.1)
 2 (1–100) 18 (13.1)
 3 (101–400) 17 (12.4)
 4 (≥ 400) 84 (61.3)
Cholesterol (mg/dl) 175 (±43.9)
LDL- cholesterol (mg/dl) 92.19 (±38.3)
HDL-cholesterol (mg/dl) 44.5 (±14.9)
Triglycerides (mg/dl) 142 (85–214)
Uric acid (mg/dl) 6.99 (± 1.54)
HbA1c (%) 6.56 (±1.62)
Albumin (g/dl) 4.05 (±0.44)
eGFR (ml/min/m2) 11.5 (4.8–22.7)
Creatinine (mg/dl) 7.51 (3.52–10.0)
Urea (mg/dl) 151 (±48.9)
Phosphorous (mg/dl) 4.65 (3.80–5.63)
Calcium (mg/dl) 9.38 (±0.72)
Calcium-phosphorus product 41.93 (36.1–50.7)
Bicarbonate (mmol/l) 19.63 (±4.99)
Intact PTH (pg/ml) 220 (94–413)
TSH (uIU/ml) 1.28 (0.79–2.78)
C-reactive protein (mg/l) 5.9 (3.13–13.1)